Literature DB >> 3198630

Ribosomal RNA processing. Limited cleavages of mouse preribosomal RNA by a nucleolar endoribonuclease include the early +650 processing site.

C M Shumard1, D C Eichler.   

Abstract

A highly purified nucleolar associated endoribonuclease was tested for possible involvement in the processing of precursor ribosomal RNA at a primary cleavage site approximately 650 nucleotides downstream from the transcription initiation site. Preribosomal RNA sequences containing the +650 region were synthesized in vitro and subsequently digested over a range of concentrations of the nucleolar endoribonuclease. Cleavages generated by the nucleolar endoribonuclease were localized both by S1 nuclease protection analysis and primer extension analysis. A more precise determination of the specificity of cleavage was achieved by chemical cleavage DNA sequence analysis. These data demonstrated that the purified nucleolar endoribonuclease specifically cleaved the precursor ribosomal RNA transcript at the +650 site. Additional enzyme-dependent cleavages were observed upstream to the +650 site in a region which is rapidly degraded following processing at the +650 site in vivo. No major cleavages were observed for a distance of approximately 250 nucleotides downstream from the +650 site in a conserved region of sequence previously shown to be important in specifying processing at the +650 site. As a control, pancreatic ribonuclease, a single strand-specific endoribonuclease, was shown not to produce similar cleavages in the +650 region, indicating that cleavage by the nucleolar RNase was not simply due to accessibility of the RNA at the +650 site. Taken together, these results suggest that the nucleolar endoribonuclease may be necessary and sufficient to catalyze one of the initial endonucleolytic cleavages in preribosomal RNA processing.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3198630

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  In vitro processing at the 3'-terminal region of pre-18S rRNA by a nucleolar endoribonuclease.

Authors:  C M Shumard; C Torres; D C Eichler
Journal:  Mol Cell Biol       Date:  1990-08       Impact factor: 4.272

2.  Sequence organization and RNA structural motifs directing the mouse primary rRNA-processing event.

Authors:  N Craig; S Kass; B Sollner-Webb
Journal:  Mol Cell Biol       Date:  1991-01       Impact factor: 4.272

3.  The virion host shutoff protein of herpes simplex virus type 1: messenger ribonucleolytic activity in vitro.

Authors:  B D Zelus; R S Stewart; J Ross
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

4.  Nucleolin functions in the first step of ribosomal RNA processing.

Authors:  H Ginisty; F Amalric; P Bouvet
Journal:  EMBO J       Date:  1998-03-02       Impact factor: 11.598

5.  U3 small nuclear RNA can be psoralen-cross-linked in vivo to the 5' external transcribed spacer of pre-ribosomal-RNA.

Authors:  R L Maser; J P Calvet
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

6.  The first pre-rRNA-processing event occurs in a large complex: analysis by gel retardation, sedimentation, and UV cross-linking.

Authors:  S Kass; B Sollner-Webb
Journal:  Mol Cell Biol       Date:  1990-09       Impact factor: 4.272

7.  RNA B is the major nucleolar trimethylguanosine-capped small nuclear RNA associated with fibrillarin and pre-rRNAs in Trypanosoma brucei.

Authors:  T Hartshorne; N Agabian
Journal:  Mol Cell Biol       Date:  1993-01       Impact factor: 4.272

8.  Selection of a preribosomal RNA processing site by a nucleolar endoribonuclease involves formation of a stable complex.

Authors:  D C Eichler; J A Liberatore; C M Shumard
Journal:  Nucleic Acids Res       Date:  1993-12-11       Impact factor: 16.971

9.  Depletion of U3 small nucleolar RNA inhibits cleavage in the 5' external transcribed spacer of yeast pre-ribosomal RNA and impairs formation of 18S ribosomal RNA.

Authors:  J M Hughes; M Ares
Journal:  EMBO J       Date:  1991-12       Impact factor: 11.598

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.